SCHEMBL9938540

SCHEMBL9938540

CC(C)(C)c1ccc(C2=C(c3ccc(NC(=O)O)cc3)CCC2=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.49
EPHX2 P34913 2/20 0.44
NR1H4 Q96RI1 2/20 0.44
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
XBP1 P17861 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
SLC6A2 P23975 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TRPV1 Q8NER1 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10006060 0.85 CYP17A1 (0.46) KIF11RAB9ANPC1SMN1; SMN2MEN1
SCHEMBL10298926 0.81 TSHR (0.50) RAB9ANPC1MAPTSLC6A2PTGS1
SCHEMBL2090691 0.79 NR1H4 (0.65) KIF11EPHX2NR1H4RAB9ANPC1
SCHEMBL10281198 0.75 PTGS1 (0.48) RAB9ANPC1SMN1; SMN2MEN1MAPT
SCHEMBL3828984 0.73 PTGS2 (0.71) PTGS1PTGS2
SCHEMBL9730038 0.73 SLC6A2 (0.42) KIF11RAB9ANPC1SLC6A2PTGS1
SCHEMBL13651401 0.69 EPHX2 (0.50) KIF11EPHX2NR1H4RAB9ANPC1
SCHEMBL28911724 0.69 EPHX2 (0.50) KIF11EPHX2NR1H4RAB9ANPC1
SCHEMBL9941076 0.68 KIF11 (0.37) KIF11RAB9ANPC1SLC6A2PTGS1
SCHEMBL9939438 0.68 PTGER2 (0.47) KIF11EPHX2NR1H4RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651885-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-10-23 EP disclosed
WO-2012083170-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-06-21 WO disclosed